JUN 14, 2017 7:12 PM PDT

Visualizing the Molecular Interactions of an Under-diagnosed Disorder

WRITTEN BY: Carmen Leitch

Myasthenia gravis is a disorder that is seldom diagnosed; it is estimated that many people have the disease and do not know it. The symptoms can vary and there are few therapeutic options for those affected but new work may help change that. Researchers have completed a three-dimensional structure of the molecular interactions at the heart of the disease, which is likely to eventually aid patients; it was published in eLife.

To solve the structure of myasthenia gravis, scientists mixed proteins from the nAChR a1 and myasthenia gravis auto-antibody, to create crystals of the nicotinic acetylcholine receptors, a neuromuscular receptor responsible for movement, as it is disrupted by the autoimmune disease, myasthenia gravis. The crystals were shot with an X-ray (synchrotron, Advanced Photon Source in Chicago) to solve the structure. / Credit: USC Chen lab and Advanced Photon Source in Chicago

"Patients are just waiting for breakthroughs in research and better treatment," explained Kaori  Noridomi, a  a doctoral candidate with Professor Lin Chen's Molecular and Computational Biology lab at the USC Dornsife College of Letters, Arts and Sciences. "They may also, because the disease attacks their immune system, end up with other diseases. I met one patient who had myasthenia gravis and had also dealt with four different types of cancer.”

Noridomi and a research team that included Chen were able to view a neural receptor that is the usual target of the disease on the molecular level for the first time. It provides insight into the mechanism of the disease; illustrating how it disrupts signals from muscle to brain. Lin Chen, the study's corresponding author and a USC Dornsife College Professor of Biological Sciences and Chemistry, is hopeful this work will lead to new therapies for the disease.

"Because of this finding, we may also find a better quantitative way to identify patients," Chen said.

While it’s considered under diagnosed by the Myasthenia Gravis Foundation of America, between 36,000 and 60,000 Americans are impacted by myasthenia gravis annually.

The treatment usually only confronts some of the symptoms of the disorder, while not addressing the causes, said Noridomi. Symptoms might include weakness in facial muscles and eyes, or arms, slurred speech or difficulty swallowing.

Myasthenia gravis has a well-defined autoimmune target, nicotinic acetylcholine receptors. In the disease, antibodies run amok attack those receptors. Those antibodies are also the ones that respond to nicotine and other drugs like it. In the muscles however, they act to transmit the signals sent by the brain to the muscle that control movement.

In the disease, the antibodies disrupt this process, interrupting the natural binding that normally occurs between the receptors in the muscles and the acetylcholine molecules.The antibodies are trying to destroy a protein within the receptors. The disease is usually diagnosed by confirming the presence of those antibodies. Learn more about the disorder from the following video.

For this work, the investigators were able to visualize the cross-linking between the rogue antibodies and the targeted proteins in the receptors in the muscles. The study indicated that it could be possible to use drugs to stop the antibodies from getting to the receptor. The wide range of disease seen in patients remains a mystery, however.

"It's a little bit of disease and a little bit of heredity that cause this," Noridomi said. "In some people, the level of symptoms may be so slight and varied that they may not even go to the trouble of finding out if they have a disease. By that, I mean, maybe they just don't feel good one day, like they don't feel like going to work. They don't know that ultimately they are suffering an attack.”

 

Sources: AAAS/Eurekalert! via USC, NINDS, eLife

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 18, 2019
Drug Discovery & Development
DEC 18, 2019
Stroke Drug Enhances Stem Cell Therapies for Spinal Cord Injuries
Using rat models of spinal cord injuries, Yasuhiro Shiga, MD, PhD, thought treating them with stem cell therapy would point to nowhere but the nature of re...
DEC 26, 2019
Cell & Molecular Biology
DEC 26, 2019
Learning More About How Mosquitoes Gain Resistance to Insecticides
When insecticides are used repeatedly over time to kill mosquitoes, they become less effective as the insects gain resistance to their impacts....
JAN 13, 2020
Cell & Molecular Biology
JAN 13, 2020
Disrupting Leukemia's Deadly Reliance on Vitamin B6
Acute Myeloid Leukemia is a cancer of the blood that starts in the bone marrow, where the stem cells that produce blood cells reside, and rapidly moves to the blood....
JAN 11, 2020
Neuroscience
JAN 11, 2020
Molecular Therapy to Self-Repair Nerve Cells
Neurodegenerative diseases such as Multiple Sclerosis (MS), Alzheimer's, and Huntington's Disease are predicated on damage to myelin on nerve cells...
JAN 27, 2020
Microbiology
JAN 27, 2020
Microbes in Household Dust May Be Spreading Antibiotic Resistance
Bacteria live in household dust, and sometimes a few of those microbes are pathogenic or carry genes that confer resistance to antibiotics....
FEB 07, 2020
Genetics & Genomics
FEB 07, 2020
Mutations That Lead to Cancer May Occur Decades Before Diagnosis
As our cells age or divide, errors can accumulate in the genome they carry, which can lead to cancer, and a variety of environmental and genetic factors ca...
Loading Comments...